Regenxbio: 'Strong Buy' On FDA Course Reversal For NAVSUNLI And Potential AA DMD Filing

REGENXBIO expects to resubmit NAVSUNLI BLA in Q3 2026, leveraging robust CAMPSIITE trial data. Read why RGNX stock is a ...
techtimes

Meta Prediction Market App Puts Llama in Charge of Deciding What Is True

Mark Zuckerberg has directed a team at Meta to build a standalone prediction market app called Arena, internal company documents obtained by NPR show — and its most consequential design choice is not ...